Linking Gut Microbiota to Colorectal Cancer
Citations Over TimeTop 10% of 2017 papers
Abstract
Pre-clinical and clinical data produce mounting evidence that the microbiota is strongly associated with colorectal carcinogenesis. Dysbiosis may change the course of carcinogenesis as microbial actions seem to impact genetic and epigenetic alterations leading to dysplasia, clonal expansion and malignant transformation. Initiation and promotion of colorectal cancer may result from direct bacterial actions, bacterial metabolites and inflammatory pathways. Newer aspects of microbiota and colorectal cancer include quorum sensing, biofilm formation, sidedness and effects/countereffects of microbiota and probiotics on chemotherapy. In the future, targeting the microbiota will probably be a powerful weapon in the battle against CRC as gut microbiology, genomics and metabolomics promise to uncover important linkages between microbiota and intestinal health.
Related Papers
- → Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients(2018)359 cited
- → Quercetin improves gut dysbiosis in antibiotic-treated mice(2020)121 cited
- → Epigenetics in Carcinogenesis and Cancer Prevention(2003)93 cited
- → The Microbiome in HIV-Infected Children(2020)1 cited
- → [Vaginal microbiome: community characteristics and disease intervention].(2021)1 cited